Login | registrati
Diax srl - Analysis - Protein - Electrophoresis - Pneumococcal Immunity Panel

Pneumococcal Immunity Panel

back

 

Upon administration of a pneumococcal vaccine, antibody response can achieve measurable concentrations in 2 to 5 weeks.  The efficacy of the vaccination is generally assessed by measuring pre- and post-vaccination antibody titers.  A 2-fold increase, or greater, is expected in most adults¹.  Published literature considers that immunoglobulin G (IgG) response varies by serotype and can be impacted by age and health status¹ ².  There is currently no documented agreement on specific post-vaccination antibody concentrations needed to establish protection from pneumococcal infection.


Assay Description
The Luminex Pneumococcal Immunity Panel utilizes Luminex xMAP® multiplexing technology to provide a quantitative assessment of IgG following administration of a pneumococcal vaccine.


xMAP® Pneumo14 contains the following pneumococcal serotypes:
American Designation
1
3
4
8
9
12
14
19
23
26
51
56
57
68
Danish Designation
1
3
4
8
9N
12F
14
19F
23F
6B
7F
18C
19A
9V


Laboratory developed enzyme-linked immunosorbent assays (ELISA) are used by major reference laboratories and hospital laboratories to measure antibody response to vaccination.  Each ELISA measures a single serotype on one plate requiring a total of 14 plates to test 14 serotypes.  By contrast the xMAP® Pneumo14 assay allows for the simultaneous measurement of all 14 serotypes from a single patient sample in a single well.  This significantly reduces the amount of labor and time to results versus traditional methods.
Comparison of xMAP® Pneumo14 to ELISA.



Inter-Laboratory Reproducibility
Since the assay is usually executed with pre- and post-vaccination samples, reproducibility is of utmost importance.  This assay demonstrates superior reproducibility in the most stringent inter-laboratory scenarios.  In this example, 80 blinded samples run at two different laboratories showed an average correlation coefficients of 0.96.


Median Correlation Coefficient r² = 0.97

Kit Contents

Microspheres coated with 14 pneumococcal serotype specific antigens
3 Controls: High (CH), Medium (CM), and Low (CL)
6 Standards and 1 Background
Conjugate
Wash Solution
Diluent

Order Information
Product Description
Product Number
xMAP® Pneumo14 (Ten Plate Kit)
BG-PNEU00014-10
xMAP® Pneumo14 (One Plate Kit)
BG-PNEU00014-01

 

DOCUMENTS
Elenco Prodotti

NAME CODE
Diax srl
via Toscana 2
20060 Vignate (MI)
P.iva IT12107160157
Protein DNA
Electrophoresis
Gene Expression
Cytokines
Fluorochromes
Precast Gel

T +39.02.95.360.619
F +39.02.95.360.992
M info@diax.it
Tutti i diritti riservati
      ByWeb Agency Milano